Dermatological findings in 61 mutation-positive individuals with cardiofaciocutaneous syndrome

D. H. Siegel, J. McKenzie, I. J. Frieden, Katherine A Rauen

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Background The RASopathies are a class of human genetic syndromes that are caused by germline mutations in genes which encode components of the Ras/mitogen-activated protein kinase (MAPK) pathway. Cardiofaciocutaneous (CFC) syndrome is characterized by distinctive craniofacial features, congenital heart defects, and abnormalities of the skin and hair. Objectives Systematically to characterize the spectrum of dermatological findings in mutation-positive individuals with CFC syndrome. Methods Dermatological surveys were designed by the authors and distributed to the study participants through CFC International or directly by the authors (K.A.R. and D.H.S.) between July 2006 and August 2009. A second follow-up survey was collected between December 2007 and August 2009. When available, digital images and medical records of the participants were obtained. Study participants included individuals with CFC syndrome who have a mutation in BRAF, MAP2K1, MAP2K2 or KRAS. Results Individuals with CFC syndrome have a variety of dermatological manifestations caused by dysregulation of the MAPK pathway in development. Numerous acquired melanocytic naevi were one of the most striking features: more than 50 naevi were reported by 23% (14/61) of participants and of those, more than 100 naevi were reported by 36% (5/14). Keratosis pilaris was reported in 80% (49/61) of cases. Ulerythema ophryogenes was common, occurring in 90% (55/61). Infantile haemangiomas occurred at a greater frequency, 26% (16/61), as compared with the general population. Conclusions CFC syndrome has a complex dermatological phenotype with many cutaneous features, some of which allow it to be differentiated from the other Ras/MAPK pathway syndromes. Multiple café-au-lait macules and papillomas were not identified in this CFC cohort, helping to distinguish CFC from other RASopathies such as neurofibromatosis type 1 and Costello syndrome.

Original languageEnglish (US)
Pages (from-to)521-529
Number of pages9
JournalBritish Journal of Dermatology
Volume164
Issue number3
DOIs
StatePublished - Mar 2011
Externally publishedYes

Fingerprint

Mutation
Mitogen-Activated Protein Kinases
Congenital Heart Defects
Nevus
Costello Syndrome
Pigmented Nevus
Skin
Neurofibromatoses
Neurofibromatosis 1
Germ-Line Mutation
Medical Genetics
Papilloma
Hemangioma
Hair
Medical Records
Cardiofaciocutaneous syndrome
Phenotype
Population
Genes
Surveys and Questionnaires

ASJC Scopus subject areas

  • Dermatology

Cite this

Dermatological findings in 61 mutation-positive individuals with cardiofaciocutaneous syndrome. / Siegel, D. H.; McKenzie, J.; Frieden, I. J.; Rauen, Katherine A.

In: British Journal of Dermatology, Vol. 164, No. 3, 03.2011, p. 521-529.

Research output: Contribution to journalArticle

@article{219a3bd2f26249099d51feb6b9e5d34c,
title = "Dermatological findings in 61 mutation-positive individuals with cardiofaciocutaneous syndrome",
abstract = "Background The RASopathies are a class of human genetic syndromes that are caused by germline mutations in genes which encode components of the Ras/mitogen-activated protein kinase (MAPK) pathway. Cardiofaciocutaneous (CFC) syndrome is characterized by distinctive craniofacial features, congenital heart defects, and abnormalities of the skin and hair. Objectives Systematically to characterize the spectrum of dermatological findings in mutation-positive individuals with CFC syndrome. Methods Dermatological surveys were designed by the authors and distributed to the study participants through CFC International or directly by the authors (K.A.R. and D.H.S.) between July 2006 and August 2009. A second follow-up survey was collected between December 2007 and August 2009. When available, digital images and medical records of the participants were obtained. Study participants included individuals with CFC syndrome who have a mutation in BRAF, MAP2K1, MAP2K2 or KRAS. Results Individuals with CFC syndrome have a variety of dermatological manifestations caused by dysregulation of the MAPK pathway in development. Numerous acquired melanocytic naevi were one of the most striking features: more than 50 naevi were reported by 23{\%} (14/61) of participants and of those, more than 100 naevi were reported by 36{\%} (5/14). Keratosis pilaris was reported in 80{\%} (49/61) of cases. Ulerythema ophryogenes was common, occurring in 90{\%} (55/61). Infantile haemangiomas occurred at a greater frequency, 26{\%} (16/61), as compared with the general population. Conclusions CFC syndrome has a complex dermatological phenotype with many cutaneous features, some of which allow it to be differentiated from the other Ras/MAPK pathway syndromes. Multiple caf{\'e}-au-lait macules and papillomas were not identified in this CFC cohort, helping to distinguish CFC from other RASopathies such as neurofibromatosis type 1 and Costello syndrome.",
author = "Siegel, {D. H.} and J. McKenzie and Frieden, {I. J.} and Rauen, {Katherine A}",
year = "2011",
month = "3",
doi = "10.1111/j.1365-2133.2010.10122.x",
language = "English (US)",
volume = "164",
pages = "521--529",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Dermatological findings in 61 mutation-positive individuals with cardiofaciocutaneous syndrome

AU - Siegel, D. H.

AU - McKenzie, J.

AU - Frieden, I. J.

AU - Rauen, Katherine A

PY - 2011/3

Y1 - 2011/3

N2 - Background The RASopathies are a class of human genetic syndromes that are caused by germline mutations in genes which encode components of the Ras/mitogen-activated protein kinase (MAPK) pathway. Cardiofaciocutaneous (CFC) syndrome is characterized by distinctive craniofacial features, congenital heart defects, and abnormalities of the skin and hair. Objectives Systematically to characterize the spectrum of dermatological findings in mutation-positive individuals with CFC syndrome. Methods Dermatological surveys were designed by the authors and distributed to the study participants through CFC International or directly by the authors (K.A.R. and D.H.S.) between July 2006 and August 2009. A second follow-up survey was collected between December 2007 and August 2009. When available, digital images and medical records of the participants were obtained. Study participants included individuals with CFC syndrome who have a mutation in BRAF, MAP2K1, MAP2K2 or KRAS. Results Individuals with CFC syndrome have a variety of dermatological manifestations caused by dysregulation of the MAPK pathway in development. Numerous acquired melanocytic naevi were one of the most striking features: more than 50 naevi were reported by 23% (14/61) of participants and of those, more than 100 naevi were reported by 36% (5/14). Keratosis pilaris was reported in 80% (49/61) of cases. Ulerythema ophryogenes was common, occurring in 90% (55/61). Infantile haemangiomas occurred at a greater frequency, 26% (16/61), as compared with the general population. Conclusions CFC syndrome has a complex dermatological phenotype with many cutaneous features, some of which allow it to be differentiated from the other Ras/MAPK pathway syndromes. Multiple café-au-lait macules and papillomas were not identified in this CFC cohort, helping to distinguish CFC from other RASopathies such as neurofibromatosis type 1 and Costello syndrome.

AB - Background The RASopathies are a class of human genetic syndromes that are caused by germline mutations in genes which encode components of the Ras/mitogen-activated protein kinase (MAPK) pathway. Cardiofaciocutaneous (CFC) syndrome is characterized by distinctive craniofacial features, congenital heart defects, and abnormalities of the skin and hair. Objectives Systematically to characterize the spectrum of dermatological findings in mutation-positive individuals with CFC syndrome. Methods Dermatological surveys were designed by the authors and distributed to the study participants through CFC International or directly by the authors (K.A.R. and D.H.S.) between July 2006 and August 2009. A second follow-up survey was collected between December 2007 and August 2009. When available, digital images and medical records of the participants were obtained. Study participants included individuals with CFC syndrome who have a mutation in BRAF, MAP2K1, MAP2K2 or KRAS. Results Individuals with CFC syndrome have a variety of dermatological manifestations caused by dysregulation of the MAPK pathway in development. Numerous acquired melanocytic naevi were one of the most striking features: more than 50 naevi were reported by 23% (14/61) of participants and of those, more than 100 naevi were reported by 36% (5/14). Keratosis pilaris was reported in 80% (49/61) of cases. Ulerythema ophryogenes was common, occurring in 90% (55/61). Infantile haemangiomas occurred at a greater frequency, 26% (16/61), as compared with the general population. Conclusions CFC syndrome has a complex dermatological phenotype with many cutaneous features, some of which allow it to be differentiated from the other Ras/MAPK pathway syndromes. Multiple café-au-lait macules and papillomas were not identified in this CFC cohort, helping to distinguish CFC from other RASopathies such as neurofibromatosis type 1 and Costello syndrome.

UR - http://www.scopus.com/inward/record.url?scp=79952429680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952429680&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2133.2010.10122.x

DO - 10.1111/j.1365-2133.2010.10122.x

M3 - Article

C2 - 21062266

AN - SCOPUS:79952429680

VL - 164

SP - 521

EP - 529

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 3

ER -